Public Company News
HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025
Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies TAIPEI, SHANGHAI and SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stag...
2025-10-20 19:00
1361
IBM and Groq Partner to Accelerate Enterprise AI Deployment with Speed and Scale
Partnership aims to deliver faster agentic AI capabilities through IBM watsonx
Orchestrate and Groq technology, enabling enterprise clients to take immediate
action on complex workflows
ARMONK, N.Y. and MOUNTAIN VIEW, Calif., Oct. 20, 2025 /PRNewswire/ -- IBM
(NYSE:IBM
2025-10-20 18:09
1133
SKF at COP30: The world can't afford friction - it's time to scale what works
GOTHENBURG, Sweden, Oct. 20, 2025 /PRNewswire/ -- SKF will be attending COP30, held in Belém,Brazil in November 2025, to drive systemic change and progress through collaboration. A resilient industry demands open, systematic collaboration. SKF sees friction every day, in mindsets, metrics, and b...
2025-10-20 17:54
909
Tiger Brokers (Hong Kong) Sponsors CFA Institute Research Challenge -- Hong Kong Local Final for the First Time, Introducing the "Star Presenter" Award
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Tiger Brokers (Hong Kong) Global Limited ("Tiger Brokers (Hong Kong)") is proud to announce its inaugural sponsorship of the 2025–2026 CFA Institute Research Challenge — Hong Kong Local Final, underscoring the firm's commitment to talent development, profe...
2025-10-20 17:40
1743
The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC
* After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to 0.62; two-sided P<0.0001). * OS was significantly longer with sac-TMT than with chemotherapy (H...
2025-10-20 17:06
1309
Global Chinese Wealth Manager Noah Holdings Hosts Inaugural N+ Art Club Exhibition in Shanghai: Hub: The Endless Exploration of Art
Extending Trust Between Cultures & Generations Through "Wisdom • Wealth • A Life of Warmth" SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-sto...
2025-10-20 16:53
2132
ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma
BERLIN, Oct. 20, 2025 /PRNewswire/ -- At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing locally advanced or metastatic urothelial carcinoma (RC48-C016)...
2025-10-20 14:58
1532
HD Hyundai Vice Chairman Chung Kisun Promoted to Chairman
SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- HD Hyundai announced that
Executive Vice ChairmanChung Kisun has been promoted to Chairman in its latest
executive appointments.
2025-10-20 14:24
1143
3M at China Wind Power 2025: innovations empowering the future of green energy
BEIJING, Oct. 20, 2025 /PRNewswire/ -- On October 20, 2025, 3M, a global leader in diversified technology, made its appearance at the 2025 China Wind Power (CWP 2025). At this year's exhibition, 3M's booth theme was "With Wind as Wings, 3M Empowers a Green Future," focusing on showcasing innovativ...
2025-10-20 14:16
1250
Agoda Spotlights Unique Asian Airports Redefining the Layover Experience
SINGAPORE, Oct. 20, 2025 /PRNewswire/ -- Digital travel platform Agoda has unveiled a list of five airports inAsia that transform layovers into memorable experiences. These airports offer more than just transit, with attractions that cater to both short and long stops, inviting travelers to arriv...
2025-10-20 14:03
1057
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, Results from a Phase 3 study of the Company's human epidermal growth factor rece...
2025-10-20 13:59
1226
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- October 20, 2025- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrou...
2025-10-20 13:21
1167
Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 2025
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ovarian cancer (OC) and HER2-positive metastatic colore...
2025-10-20 13:15
1282
Zeekr Group to Report Third Quarter 2025 Financial Results on November 17, 2025
HANGZHOU, China, Oct. 20, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it will report its unaudited financial results for the third quarter endedSeptember 3...
2025-10-20 13:00
1538
KLN Drives Libya's Wellhead Platform A Project Toward Completion, One of the Mediterranean Sea's Largest Offshore EPCI Projects to Bolster Energy Infrastructure
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK), through its division KLN Project, today announced significant progress on the Wellhead Platform A (WHPA) project inLibya's Bahr Essalam field. As consortium leader appointed by Mellitah Oil & Gas Co...
2025-10-20 12:29
1161
Nongshim Shin Ramyun Light Ups New York Times Square with 'KPop Demon Hunters'
- Global campaign celebrates the U.S. debut of the movie-inspired collaboration package - NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Nongshim carried out a global campaign at New York Times Square to celebrate the launch of Shin Ramyun in collaboration with Netflix's hit animated film 'KPop Demon H...
2025-10-20 11:23
1219
Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's trophoblast cell-s...
2025-10-20 10:36
1257
Agoda and Premier Inn Partner to Capture Rising Asian Traveler Interest in UK and Europe
The partnership aims to connect travelers from Asia and beyond to over 900 properties across the UK,Germany and Ireland SINGAPORE, Oct. 20, 2025 /PRNewswire/ -- Global digital travel platform Agoda has announced a new partnership with theUnited Kingdom's (UK) largest hotel chain Premier Inn maki...
2025-10-20 10:30
1331
Save Now, Travel through March: T'way Air Announces Fall Savings to Korea
Promo Code FLYOCT & Special Coupons for Travel through March 2026
TAIPEI, Oct. 20, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost
carrier, invites travelers to enjoy special savings throughOctober 31 on
Taiwan-Korea bookings for travel untilMarch 28, 2026.
2025-10-20 09:00
1239
Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability
SHANGHAI and HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic ma...
2025-10-20 09:00
1163
Week's Top Stories
Most Reposted
Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
[Picked up by 309 media titles]
2026-01-15 13:00Colebrook Bosson Saunders Launches Lana: An Adaptable Laptop Stand Engineered for Hybrid Work
[Picked up by 305 media titles]
2026-01-12 16:16
Ready Server Announces Strategic Expansion into Japan with AT TOKYO Data Centre
[Picked up by 301 media titles]
2026-01-13 13:16
CAYIN AI: Revolutionizing Creativity and Global Communication
[Picked up by 300 media titles]
2026-01-12 16:34
JIOS Aerogel® Secures Hyundai Contract Through New Licensing Model
[Picked up by 298 media titles]
2026-01-15 10:00Most Read
GIGABYTE Strengthens NVIDIA® Partnership to Drive Innovation in AI-Powered Gaming and Creative Solutions
2026-01-17 00:00
5726
